Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $144.7450 (3.4%) ($144.7450 - $144.7450) on Wed. Apr. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.1% (three month average) | RSI | 61 | Latest Price | $144.7450(3.4%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 1.2% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(50%) XBI(43%) ARKG(36%) IWO(34%) ARKK(31%) | Factors Impacting SGEN price | SGEN will decline at least -1.55% in a week (0% probabilities). VIXM(-22%) VXX(-10%) UUP(-8%) TBT(-3%) USO(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.55% (StdDev 3.1%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $142.62(1.49%) | 10 Day Moving Average | $143(1.22%) | 20 Day Moving Average | $142.88(1.31%) | To recent high | -24.4% | To recent low | 5.4% | Market Cap | $25.166b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |